use
sydney
popul
estim
use
data
state
new
south
wale
new
york
popul
year
deriv
relev
statist
collect
divid
popul
age
group
age
year
combin
eldest
person
year
age
singl
group
figur
panel
age
group
divid
vaccin
unvaccin
compart
subdivid
categori
immun
immunocompet
mildli
immunosuppress
moderatetosever
immunosuppress
assum
immunosuppress
person
residu
immun
vaccin
consid
common
type
immunosuppress
estim
influenza
studi
classifi
person
categori
immunosuppress
moder
sever
call
sever
model
mild
sever
immunosuppress
defin
condit
quantifi
data
exist
demonstr
risk
infect
twice
immunocompet
person
classif
left
singl
categori
absenc
reliabl
methodolog
subdivid
mild
immunosuppress
defin
condit
immunosuppress
document
suscept
infect
estim
less
twice
immunocompet
host
analysi
person
sever
immunosuppress
assum
mild
immunosuppress
suscept
infect
healthi
person
sourc
data
citi
countrywid
data
avail
attribut
rate
countrywid
data
set
respect
fraction
popul
citi
agespecif
immunosuppress
preval
data
avail
use
yearli
agespecif
incid
data
instead
calcul
preval
age
distribut
estim
popul
live
cancer
hiv
organ
transplant
respiratori
syndrom
asthma
chronic
obstruct
pulmonari
diseas
dialysi
autoimmun
diseas
divid
popul
immunosuppress
categori
citi
technic
appendix
tabl
acknowledg
mani
diseas
associ
immunosuppress
method
underestim
amount
immunosuppress
popul
unit
state
includ
new
york
widespread
smallpox
vaccin
occur
contrast
geograph
isol
island
contin
australia
quarantin
use
protect
popul
smallpox
never
endem
widespread
vaccin
never
occur
australia
arm
forc
healthcar
worker
vaccin
occur
although
reactiv
vaccin
campaign
conduct
smallpox
outbreak
sydney
new
york
assum
healthi
popul
year
age
born
previous
vaccin
sydney
estim
proport
person
vaccin
estim
born
follow
group
healthcar
worker
sydney
member
defens
forc
migrant
sydney
popul
might
vaccin
countri
origin
person
estim
sydney
total
popul
born
person
year
age
vaccin
basi
mathemat
model
estim
wane
immun
sever
smallpox
per
year
vaccin
calcul
agespecif
residu
protect
vaccin
person
year
age
multipli
percentag
number
year
vaccin
subtract
start
protect
model
use
heterogen
agespecif
contact
rate
european
mix
pattern
studi
assum
person
would
greatli
reduc
social
contact
becom
symptomat
smallpox
account
chang
social
contact
modifi
normal
contact
matrix
multipli
matrix
factor
x
reduc
number
contact
per
day
lack
studi
quantifi
reduct
assum
x
previou
studi
consid
sever
smallpox
type
substanti
prostrat
appli
reduc
contact
matrix
hemorrhag
flat
smallpox
infect
first
day
ill
ordinari
smallpox
assum
behavior
chang
start
second
day
vaccinemodifi
smallpox
third
day
categor
smallpox
diseas
differ
type
defin
infect
cfr
hemorrhag
flat
ordinari
vaccinemodifi
agespecif
model
paramet
technic
appendix
tabl
well
model
detail
explain
technic
appendix
assum
infect
person
differ
probabl
develop
diseas
type
depend
age
immunolog
statu
incid
diseas
type
within
age
group
healthi
unvaccin
person
drawn
histor
outbreak
technic
appendix
tabl
healthi
unvaccin
person
hemorrhag
smallpox
ratio
rang
person
infect
age
group
person
infect
age
group
flat
smallpox
agespecif
rate
lowest
age
group
person
infect
reach
person
infect
oldest
age
group
mildli
immunocompromis
popul
doubl
agespecif
probabl
hemorrhag
flat
smallpox
assum
sever
immunocompromis
person
would
develop
hemorrhag
diseas
assum
vaccin
subgroup
reduc
suscept
rate
sever
smallpox
type
estim
vaccin
person
would
get
vaccinemodifi
smallpox
appli
wane
immun
function
time
rate
per
year
vaccin
assum
rate
hemorrhag
flat
smallpox
would
increas
time
vaccin
rate
vaccinemodifi
smallpox
would
decreas
time
vaccin
technic
appendix
tabl
construct
modifi
seir
suscept
expos
infect
recov
model
smallpox
transmiss
technic
appendix
tabl
popul
divid
vaccin
unvaccin
compart
subdivid
categori
immun
immunocompet
mildli
immunosuppress
moderatetosever
immunosuppress
model
use
ordinari
differenti
equat
move
popul
epidemiolog
state
relat
smallpox
infecti
statu
suscept
infect
prodrom
infecti
recov
dead
infect
popul
move
next
state
basi
diseas
durat
rate
obtain
agespecif
forc
infect
ie
rate
suscept
person
acquir
smallpox
use
euler
approxim
make
discret
contact
rate
assum
rate
proport
pattern
observ
unit
kingdom
account
differ
infect
rate
differ
smallpox
type
estim
transmiss
paramet
ie
probabl
get
infect
contact
smallpox
diseas
type
calcul
hemorrhag
flat
ordinari
vaccinemodifi
smallpox
final
multipli
forc
infect
paramet
technic
appendix
tabl
account
differ
suscept
level
differ
popul
model
ran
simul
day
assum
attack
crowd
public
space
airport
start
epidem
infect
new
york
sydney
reflect
attack
rate
popul
assum
dynam
popul
updat
day
use
birth
agespecif
death
rate
citi
conduct
sensit
analysi
assumpt
wane
immun
reduc
immun
per
year
approxim
half
valu
use
base
case
scenario
ie
first
scenario
discuss
present
result
differ
assumpt
residu
vaccin
immun
residu
immun
base
case
immun
wane
immun
per
year
high
residu
immun
wane
immun
per
year
also
conduct
sensit
analysi
test
model
output
without
consid
popul
immunosuppress
approach
past
model
examin
popul
age
distribut
new
york
sydney
sydney
higher
percentag
person
year
age
new
york
figur
panel
wherea
new
york
higher
proport
person
year
age
sydney
estim
new
york
popul
sydney
popul
sever
immunocompromis
new
york
popul
sydney
popul
mildli
immunocompromis
new
york
popul
sydney
popul
healthi
unvaccin
new
york
popul
sydney
popul
healthi
vaccin
similar
proport
citi
popul
new
york
sydney
immunosuppress
figur
panel
b
new
york
higher
proport
popul
vaccin
sydney
analyz
agespecif
infect
figur
panel
death
figur
panel
b
rate
use
base
case
scenario
medium
immun
level
includ
immunosuppress
popul
person
year
age
highest
risk
smallpox
infect
citi
figur
panel
although
proport
person
infect
citi
similar
among
age
group
person
new
york
sydney
becom
infect
among
age
group
cumul
death
per
popul
increas
age
start
person
year
age
figur
panel
b
death
peak
age
group
citi
reach
popul
new
york
popul
sydney
day
start
outbreak
rate
increas
year
age
new
york
popul
also
smaller
peak
death
age
group
although
spread
infect
mostli
driven
higher
contact
rate
among
person
young
age
group
peak
death
reflect
distribut
immunosuppress
popul
figur
panel
b
figur
panel
b
effect
residu
immun
appar
new
york
trend
show
greater
decreas
infect
cumul
death
age
group
previous
vaccin
year
age
look
total
rate
time
new
york
figur
panel
c
sydney
figur
panel
b
similar
exponenti
growth
infect
rate
slightli
higher
trend
new
york
rate
infect
reach
popul
new
york
popul
sydney
day
smallpox
introduct
increas
popul
new
york
popul
sydney
day
death
rate
popul
new
york
popul
sydney
day
reach
popul
new
york
popul
sydney
day
infect
death
rate
estim
new
york
vaccin
coverag
doubl
sydney
sensit
assumpt
residu
immun
new
york
figur
panel
lower
rate
infect
sydney
figur
panel
b
scenario
high
residu
immun
day
outbreak
rate
base
case
residu
immun
high
residu
immun
lower
new
york
base
case
residu
immun
high
residu
immun
lower
sydney
residu
immun
without
residu
immun
differ
infect
death
rate
among
differ
residu
immun
assumpt
increas
time
regard
impact
agespecif
rate
new
york
figur
panel
sydney
figur
panel
b
assumpt
high
residu
immun
produc
lower
death
rate
older
age
group
infect
death
rate
increas
includ
vs
exclud
immunosuppress
paramet
model
greater
differ
seen
new
york
infect
rate
figur
panel
c
sydney
infect
rate
figur
panel
differ
rate
increas
time
reach
new
york
sydney
day
start
outbreak
new
york
sydney
day
although
includ
immunosuppress
estim
model
produc
similarli
higher
infect
rate
age
group
less
age
group
differ
death
rate
increas
age
figur
pass
year
popul
immunosuppress
influenti
determin
residu
vaccin
immun
sever
smallpox
epidem
although
spread
diseas
highest
younger
age
group
driven
mostli
higher
contact
rate
higher
death
rate
seen
older
popul
reflect
preval
immunosuppress
differ
new
york
high
vaccin
coverag
estim
popul
sydney
low
vaccin
coverag
demonstr
residu
immun
assumpt
influenti
sydney
new
york
howev
consider
popul
immunosuppress
medic
condit
iatrogen
factor
strongli
affect
diseas
transmiss
death
citi
larg
popul
subset
must
consid
model
impact
infecti
diseas
outbreak
estim
conserv
almost
person
new
york
person
sydney
higher
age
group
live
degre
immunosuppress
although
new
york
higher
rate
immunosuppress
age
group
sydney
higher
rate
new
york
youngest
year
oldest
popul
residu
immun
affect
agespecif
infect
death
rate
citi
show
highest
infect
rate
unvaccin
young
person
year
age
howev
death
rate
rise
year
age
despit
higher
vaccin
coverag
age
group
sydney
even
assumpt
higher
immun
affect
infect
death
rate
greatli
low
vaccin
coverag
howev
residu
immun
becom
influenti
use
optimist
assumpt
wane
immun
note
person
vaccin
would
mount
robust
rapid
respons
revaccin
event
outbreak
might
better
protect
postexposur
vaccin
obtain
vaccin
histori
check
consist
scar
necessari
part
outbreak
manag
although
immunosuppress
major
determin
size
distribut
smallpox
outbreak
fact
major
determin
vaccin
polici
immunosuppress
continu
absolut
contraind
vaccin
person
true
contact
ensur
person
immunosuppress
includ
healthcar
worker
avoid
contact
person
smallpox
possibl
prioriti
smallpox
would
alway
pathogen
vaccinia
viru
patient
bona
fide
exposur
smallpox
vaccin
fulli
potent
vaccinia
strain
patient
develop
seriou
complic
eczema
vaccinatum
progress
vaccinia
patient
treat
siga
technolog
new
york
ny
usa
studi
subject
limit
use
underestim
immunosuppress
condit
caus
immunosuppress
diabet
consid
also
use
conserv
estim
increas
risk
infect
immunosuppress
person
group
person
sever
moder
immunosuppress
singl
categori
absenc
specif
data
categor
degre
immunosuppress
contact
matrix
use
estim
studi
conduct
unit
kingdom
might
necessarili
reflect
new
york
sydney
social
contact
pattern
furthermor
contact
symptomat
infecti
patient
probabl
drop
near
zero
outbreak
confirm
patient
well
isol
assum
adequ
health
system
capac
isol
treatment
smallpox
patient
data
model
agespecif
rate
smallpox
obtain
hospit
patient
might
overestim
rate
sever
diseas
model
output
speed
vigor
smallpox
control
effort
implement
major
aspect
control
effort
need
test
model
account
adequ
immunosuppress
ensur
adequ
hospit
care
isol
facil
also
help
epidem
control
ebola
epidem
west
africa
lack
bed
result
widespread
commun
transmiss
model
show
patient
need
treatment
facil
control
epidem
respons
sever
acut
respiratori
syndrom
rapid
control
despit
lack
vaccin
antivir
agent
show
patient
isol
success
experi
sever
acut
respiratori
syndrom
ebola
middl
east
respiratori
syncyti
coronaviru
also
illustr
heavi
toll
healthcar
worker
assum
high
risk
infect
event
smallpox
outbreak
given
wane
smallpox
vaccin
immun
nearli
decad
sinc
erad
dwindl
vaccin
popul
influenc
popul
immunosuppress
greater
residu
vaccin
immun
yet
adequ
consid
smallpox
epidem
model
advanc
medicin
new
endem
diseas
hiv
result
almost
person
live
immunosuppress
larg
metropolitan
citi
immunosuppress
must
consid
prepared
plan
pose
challeng
vaccin
strategi
potenti
smallpox
outbreak
